Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al
Since its discovery, GLP-1 has emerged as an incretin hormone for its facilitation in insulin release and reduction of insulin resistance (IR)
Use single-agent reninangiotensin system inhibitors at maximally tolerated doses and, when appropriate, sodium-glucose cotransporter-2 inhibitors and finerenone to slow the progression of DKD
It also covered laboratory tests (organized using Logical Observation Identifiers Names and Codes) and healthcare utilization records from a network of 79 healthcare organizations including hospitals, primary care facilities, and specialist care providers
Full article here: To view or add a comment, sign in Around the world, millions of people who live with #obesity are at the point in their weight loss journey where, after successfully accessing and using prescription weight loss medications such as Wegovy or Mounjaro and having reached their initial weight loss goal, ask: what's next
Further electrophysiological study showed that, opposite to the effects on arcuate POMC neurons, GLP-1 hyperpolarizes arcuate NPY neurons indirectly via increased GABA A receptor-mediated neurotransmission of local GABAergic interneurons ( Morphological studies demonstrated a particularly high density of GLP-1R expression in the PVN of mice ( Different neural circuits have been proposed to maintain energy homeostasis